Your browser doesn't support javascript.
loading
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus.
Hess, Georg; Rule, Simon; Jurczak, Wojciech; Jerkeman, Mats; Santucci Silva, Rodrigo; Rusconi, Chiara; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Zhou, Wenjiong; Goldberg, Jenna D; Trambitas, Cristina; Enny, Christopher; Vermeulen, Jessica; Traina, Shana; Chiou, Chiun-Fang; Diels, Joris; Dreyling, Martin.
Afiliación
  • Hess G; a Department of Hematology, Oncology and Pneumology , University Medical School of the Johannes Gutenberg University , Mainz , Germany.
  • Rule S; b Derriford Hospital, Plymouth University Medical School , Plymouth , UK.
  • Jurczak W; c Department of Hematology , Jagiellonian University , Krakow , Poland.
  • Jerkeman M; d Skånes University Hospital, Lund University , Lund , Sweden.
  • Santucci Silva R; e Instituto de Ensino e Pesquisa Sao Lucas , Sao Paulo , Brazil.
  • Rusconi C; f Division of Hematology, Department of Hematology and Oncology, Niguarda Cancer Center , Niguarda Hospital , Milan , Italy.
  • Caballero D; g Instituto Biosanitario de Salamanca, Hospital Clinico Universitario Salamanca , Salamanca , Spain.
  • Joao C; h Institutto Português de Oncologia de Lisboa, Portugal and Champalimaud Centre for the Unknown, Hematology , Lisbon , Portugal.
  • Witzens-Harig M; i Klinikum der Ruprechts-Karls-Universität Heidelberg - Med. Klinik u. Poliklinik V , Heidelberg , Germany.
  • Bence-Bruckler I; j The Ottawa Hospital, General Campus , Ottawa , ON , Canada.
  • Cho SG; k Seoul St. Mary's Hospital , Seocho-gu , Seoul , South Korea.
  • Zhou W; l Janssen Research & Development , Raritan , NJ , USA.
  • Goldberg JD; l Janssen Research & Development , Raritan , NJ , USA.
  • Trambitas C; m Janssen Inc , Ontario , Canada.
  • Enny C; l Janssen Research & Development , Raritan , NJ , USA.
  • Vermeulen J; n Janssen Research & Development, LLC , Leiden , The Netherlands.
  • Traina S; l Janssen Research & Development , Raritan , NJ , USA.
  • Chiou CF; l Janssen Research & Development , Raritan , NJ , USA.
  • Diels J; o Janssen Pharmaceuticals , Beerse , Belgium.
  • Dreyling M; p Department of Medicine III , Klinikum der Universität München, LMU , Munich , Germany.
Leuk Lymphoma ; 58(12): 2824-2832, 2017 12.
Article en En | MEDLINE | ID: mdl-28556689
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células del Manto Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células del Manto Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos